BioVie's terlipressin liquid formulation patent approved in Japan, securing its place in the US, India, and Chile. The stable formulation benefits patients with cirrhosis and ascites, providing a significant advantage for home-care treatment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing